NOV Inc. (NYSE:NOV – Free Report) – Investment analysts at Atb Cap Markets cut their Q2 2025 earnings per share estimates for shares of NOV in a research note issued on Tuesday, April 30th. Atb Cap Markets analyst W. Syed now anticipates that the oil and gas exploration company will post earnings of $0.40 per share for the quarter, down from their prior estimate of $0.42. The consensus estimate for NOV’s current full-year earnings is $1.54 per share. Atb Cap Markets also issued estimates for NOV’s Q4 2025 earnings at $0.62 EPS, FY2025 earnings at $1.86 EPS and FY2026 earnings at $2.31 EPS.
NOV (NYSE:NOV – Get Free Report) last released its quarterly earnings data on Thursday, April 25th. The oil and gas exploration company reported $0.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.03. NOV had a net margin of 11.23% and a return on equity of 10.21%. The company had revenue of $2.16 billion during the quarter, compared to the consensus estimate of $2.11 billion. During the same period in the previous year, the firm earned $0.32 earnings per share. NOV’s revenue for the quarter was up 9.8% on a year-over-year basis.
Check Out Our Latest Report on NOV
NOV Stock Down 0.1 %
Shares of NOV stock opened at $18.54 on Friday. NOV has a twelve month low of $14.05 and a twelve month high of $21.91. The stock has a market cap of $7.33 billion, a price-to-earnings ratio of 7.45, a price-to-earnings-growth ratio of 0.79 and a beta of 1.74. The company has a current ratio of 2.50, a quick ratio of 1.50 and a debt-to-equity ratio of 0.28. The company has a fifty day moving average price of $18.71 and a 200 day moving average price of $19.12.
Institutional Inflows and Outflows
Large investors have recently bought and sold shares of the company. CENTRAL TRUST Co boosted its position in shares of NOV by 85.4% during the 3rd quarter. CENTRAL TRUST Co now owns 1,259 shares of the oil and gas exploration company’s stock valued at $26,000 after purchasing an additional 580 shares in the last quarter. Rise Advisors LLC bought a new stake in NOV during the first quarter worth approximately $26,000. Riverview Trust Co acquired a new position in NOV in the first quarter worth approximately $39,000. Bruce G. Allen Investments LLC bought a new position in shares of NOV in the fourth quarter valued at $49,000. Finally, GAMMA Investing LLC acquired a new stake in shares of NOV during the 4th quarter valued at $61,000. Institutional investors own 93.27% of the company’s stock.
Insider Transactions at NOV
In related news, CAO Christy Lynn Novak sold 3,500 shares of the firm’s stock in a transaction that occurred on Thursday, February 22nd. The shares were sold at an average price of $17.43, for a total transaction of $61,005.00. Following the transaction, the chief accounting officer now owns 114,212 shares in the company, valued at $1,990,715.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 1.85% of the company’s stock.
NOV Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Thursday, March 28th. Shareholders of record on Thursday, March 14th were given a dividend of $0.05 per share. The ex-dividend date of this dividend was Wednesday, March 13th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 1.08%. NOV’s dividend payout ratio (DPR) is 8.03%.
About NOV
NOV Inc designs, constructs, manufactures, and sells systems, components, and products for oil and gas drilling and production, and industrial and renewable energy sectors in the United States and internationally. It operates through two segments, Energy Equipment, and Energy Products and Services. The company provides solids control and waste management equipment and services, managed pressure drilling, drilling fluids, premium drillpipe, wired pipe, drilling optimization services, tubular inspection and coating services, instrumentation, downhole tools, and drill bits.
Further Reading
- Five stocks we like better than NOV
- 3 Healthcare Dividend Stocks to Buy
- Appleās Earnings Show Investors Its Strength and Its Weakness
- What Are Dividend Champions? How to Invest in the Champions
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
- Compound Interest and Why It Matters When Investing
- DraftKings Q1: Strong Customer Acquisition and Product Innovation
Receive News & Ratings for NOV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NOV and related companies with MarketBeat.com's FREE daily email newsletter.